Topological analysis of MAPK cascade for kinetic ErbB signaling

PLoS ONE

Volumn 3, Issue 3, 2008, Pages

  Nakakuki, Takashi ^a   Yumoto, Noriko ^a   Naka, Takashi ^b   Shirouzu, Mikako ^a   Yokoyama, Shigeyuki ^a,c   Hatakeyama, Mariko ^a  

^a RIKEN YOKOHAMA INSTITUTE   (Japan)

^b KYUSHU SANGYO UNIVERSITY   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

B RAF KINASE; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 4; GROWTH FACTOR RECEPTOR BOUND PROTEIN 2; MITOGEN ACTIVATED PROTEIN KINASE; RAF PROTEIN; RAP1 PROTEIN; RAS PROTEIN; SOS PROTEIN;

ANIMAL CELL; ARTICLE; CHO CELL; CONTROLLED STUDY; DIMERIZATION; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME REGULATION; NONHUMAN; POSITIVE FEEDBACK; PROTEIN PROTEIN INTERACTION; RELIABILITY; REPRODUCIBILITY; SENSITIVITY ANALYSIS; SIGNAL TRANSDUCTION; STEADY STATE; ANIMAL; CRICETULUS; HAMSTER; HUMAN; KINETICS; METABOLISM; PHOSPHORYLATION; THEORETICAL MODEL; WESTERN BLOTTING;

CRICETULUS GRISEUS;

ANIMALS; BLOTTING, WESTERN; CHO CELLS; CRICETINAE; CRICETULUS; HUMANS; KINETICS; MITOGEN-ACTIVATED PROTEIN KINASES; MODELS, THEORETICAL; PHOSPHORYLATION; RECEPTOR, EPIDERMAL GROWTH FACTOR; SIGNAL TRANSDUCTION;

EID: 46349090581     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0001782     Document Type: Article

References (49)

1. Olayioye MA, Neve RM, Lane HA, Hynes NE (2000) The ErbB signaling network: receptor heterodimerization in development and cancer. EMBO J 19: 3159-3167.
2. Yarden Y, Sliwkowski MX (2001) Untangling the ErbB signalling network. Nat Rev Mol Cell Biol 2: 127-137.
3. Wiseman SM, Makretsov N, Nielsen TO, Gilks B, Yorida E, et al. (2005) Coexpression of the type I growth factor receptor family members HER-1, HER-2, and HER-3 has a synergistic negative prognostic effect on breast carcinoma survival. Cancer 103: 1770-1777.
4. Xia W, Lau YK, Zhang HZ, Xiao FY, Johnston DA, et al. (1999) Combination of EGFR, HER-2/neu, and HER-3 is a stronger predictor for the outcome of oral squamous cell carcinoma than any individual family members. Clin Cancer Res 5: 4164-4174.
5. Graus-Porta D, Beerli RR, Daly JM, Hynes NE (1997) ErhB-2, the preferred heterodimerization partner of all ErbB receptors, is a mediator of lateral signaling. EMBO J 16: 1647-1655.
6. Holbro T, Beerli RR, Maurer F, Koziczak M, Barbas CF 3rd, et al. (2003) The ErbB2/ErbB3 heterodimer functions as an oncogenic unit: ErbB2 requires ErbB3 to drive breast tumor cell proliferation. Proc Natl Acad Sci U S A 100: 8933-8938.
7. Schulze WX, Deng L, Maun M (2005) Phosphotyrosine interactome of the ErbB-rcceptor kinase family. Mol Syst Biol 1: 2005.0008.
8. Alroy I, Yarden Y (1997) The ErbB signaling network in embryogenesis and oncogenesis: signal diversification through combinatorial ligand-receptor interactions. FEBS Lett 410: 83-86.
9. Baulida J, Kraus MH, Alimandi M, Di Fiore PP, Carpenter G (1996) All ErbB receptors other than the epidermal growth factor receptor are endocytosis impaired. J Biol Chem 271: 5251-5257.
10. Cohen BD, Kiener PA, Green JM, Foy L, Fell HP, et al. (1996) The relationship between human epidermal growth-like factor receptor expression and cellular transformation in NIH3T3 cells. J Biol Chem 271: 30897-30903.
11. Nagashima T, Shimodaira H, Ide K, Nakakuki T, Tani Y, et al. (2007) Quantitative transcriptional control of ErbB receptor signaling undergoes graded to biphasic response for cell differentiation. J Biol Chem 282: 4045-4056.
12. Kao S, Jaiswal RK, Kolch W, Landreth GE (2001) Identification of the mechanisms regulating the differential activation of the mapk cascade by epidermal growth factor and nerve growth factor in PC12 cells. J Biol Chem 276: 18169-18177.
13. Klinghoffer RA, Mueting-Nelsen PF, Faerman A, Shani M, Soriano P (2001) The two PDGF receptors maintain conserved signaling in vivo despite divergent embryological functions. Mol Cell 7: 343-354.
14. Moelling K, Schad K, Bosse M, Zimmermann S, Schweneker M (2002) Regulation of Raf-Akt Cross-talk. J Biol Chem 277: 31099-31106.
15. Reusch HP, Zimmermann S, Schaefer M, Paul M, Moelling K (2001) Regulation of Raf by Akt controls growth and differentiation in vascular smooth muscle cells. J Biol Chem 276: 33630-33637.
16. Chen D, Waters SB, Holt KH, Pessin JE (1996) SOS phosphorylation and disassociation of the Grb2-SOS complex by the ERK and JNK signaling pathways. J Biol Chem 271: 6328-3632.
17. Holt KH, Waters SB, Okada S, Yamauchi K, Decker SJ, et al. (1996) Epidermal growth factor receptor targeting prevents uncoupling of the Grb2-SOS complex. J Biol Chem 271: 8300-8306.
18. Balan V, Leicht DT, Zhu J, Balan K, Kaphin A, et al. (2006) Identification of novel in vivo Raf-1 phosphorylation sites mediating positive feedback Raf-1 regulation by extracellular signal-regulated kinase. Mol Biol Cell 17: 1141-1153.
19. Brummer T, Naegele H, Reth M, Misawa Y (2003) Identification of novel ERK-mediated feedback phosphorylation sites at the C-terminus of B-Raf. Oncogene 22: 8823-8834.
20. Dougherty MK, Muller J, Ritt DA, Zhou M, Zhou XZ, et al. (2005) Regulation of Raf-1 by direct feedback phosphorylation. Mol Cell 17: 215-224.
21. Hatakeyama M, Yumoto N, Yu X, Shirouzu M, Yokoyama S, et al. (2004) Transformation potency of ErbB heterodimer signaling is determined by B-Raf kinase. Oncogene 23: 5023-5031.
22. Garnett MJ, Rana S, Paterson H, Barford D, Marais R (2005) Wild-type and mutant B-RAF activate C-RAF through distinct mechanisms involving heterodimerization. Mol Cell 20: 963-969.
23. Rushworth LK, Hindley AD, O'Neill E, Kolch W (2006) Regulation and role of Raf-1/B-Raf heterodimerization. Mol Cell Biol 26: 2262-2272.
24. Heinrich R, Neel BG, Rapoport TA (2002) Mathematical models of protein kinase signal transduction. Mol Cel 9: 957-70.
25. Huang CY, Ferrell JE (1996) Ultrasensitivity in the mitogen-activated protein kinase cascade. Proc Natl Acad Sci U S A 93: 10078-10083.
26. Kholodenko BN, Demin OV, Moehren G, Hoek JB (1999) Quantification of short term signaling by the epidermal growth factor receptor. J Biol Chem 274: 30169-30181.
27. Favata MF, Horiuchi KY, Manus EJ, Daulerio AJ, Stradley DA, et al. (1998) Identification of a novel inhibitor of mitogen-activated protein kinase kinase. J Biol Chem 273: 18623-1862332.
28. Markevich NI, Hoek JB, Kholodenko BN (2004) Signaling switches and bistability arising from multisite phosphorylation in protein kinase cascades. J Cell Biol 164: 353-359.
29. Hatakeyama M, Kimura S, Naka T, Kawasaki T, Yumoto N, et al. (2003) A computational model on the modulation of mitogen-activated protein kinase (MAPK) and Akt pathways in heregulin-induced ErbB signalling. Biochem J 373: 451-463.
30. Brightman FA, Fell DA (2000) Differential feedback regulation of the MAPK cascade underlies the quantitative differences in EGF and NGF signalling in PC12 cells. FEBS Lett 482: 169-174.
31. Kolch W (2000) Meaningful relationships: the regulation of the Ras/Raf/ MEK/ERK pathway by protein interactions. Biochem J 351: 289-305.
32. Maruta H, Burgess AW (1994) Regulation of the Ras signalling network. Bioessays 16: 489-496.
33. Yumoto N, Yu X, Hatakeyama M (2006) Expression of the ErbB4 receptor causes reversal regulation of PP2A in the She signal transduction pathway in human cancer cells. Mol Cell Biochem 285: 165-171.
34. Roberts PJ, Der CJ (2007) Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer. Oncogene 26: 3291-3310.
35. Marais R, Light Y, Paterson HF, Mason CS, Marshall CJ (1997) Differential regulation of Raf-1, A-Raf, and B-Raf by oncogenic ras and tyrosine kinases. J Biol Chem 272: 4378-4783.
36. Santos SD, Verveer PJ, Bastiaens PI (2007) Growth factor-induced MAPK network topology shapes Erk response determining PC-12 cell fate. Nat Cell Biol 9: 324-330.
37. York RD, Yao H, Dillon T, Ellig CL, Eckert SP, et al. (1998) Rap1 mediates sustained MAP kinase activation induced by nerve growth factor. Nature 392: 622-626.
38. Campa MJ, Chang KJ, Molina y Vedia L, Reep BR, Lapetina EG (1991) Inhibition of ras-induced germinal vesicle breakdown in Xenopus oocytes by rap-1B. Biochem Biophys Res Common 174: 1-5.
39. Cook SJ, Rubinfeld B, Albert I, McCormick F (1993) RapV12 antagonizes Ras-dependent activation of ERK1 and ERK2 by LPA and EGF in Rat-1 fibroblasts. EMBO J 12: 3475-3485.
40. Vossler MR, Yao H, York RD, Pan MG, Rim CS, et al. (1997) cAMP activates MAP kinase and Elk-1 through a B-Raf- and Rap1-dependent pathway. Cell 89: 73-82.
41. Zwartkruis FJ, Wolthuis Rfvf, Nabben NM, Franke B, Bus JL (1998) Extracellular signal-regulated activation of Rap1 fails to interfere in Ras effector signalling. EMBO J 17: 5905-5912.
42. Schoeberl B, Eichler-Jonsson C, Gilles ED, Muller G (2002) Computational modeling of the dynamics of the MAP kinase cascade activated by surface and internalized EGF receptors. Nat Biotechnol 20: 370-375.
43. Shankaran H, Wiley HS, Resat H (2006) Modeling the effects of HER/ ErbB1-3 coexpression on receptor dimerization and biological response. Biophys J 90: 3993-4009.
44. Kim JH, Saito K, Yokoyama S (2002) Chimeric receptor analyses of the interactions of the ectodomains of ErbB-1 with epidermal growth factor and of those of ErbB-4 with neuregulin. Eur J Biochem 269: 2323-2329.
45. Dhillon AS, Kolch W (2002) Untying the regulation of the Raf-1 kinase. Arch Biochem Biophys 404: 3-9.
46. Kubicek M, Pacher M, Abraham D, Podar K, Eulitz M, et al. (2002) Dephosphorylation of Ser-259 regulates Raf-1 membrane association. J Biol Chem 277: 7913-7919.
47. Zhou B, Wang ZX, Zhao Y, Brautigan DL, Zhang ZY (2002) The specificity of extracellular signal-regulated kinase 2 dephosphorylation by protein phosphatases. J Biol Chem 277: 31818-31825.
48. Keyse SM (2000) Protein phosphatases and the regulation of mitogen-activated protein kinase signalling. Curr Opin Cell Biol 12: 186-192.
49. Kimura S, Konagaya A (2003) High Dimensional Function Optimization using a new Genetic Local Search suitable for Parallel Computers. Proc. of the 2003 Int. Conf. on Systems, Man, and Cybernetics, 335-342.